{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:36:18Z","timestamp":1761172578331,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.mycmed.2017.02.004","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T21:01:25Z","timestamp":1490734885000},"page":"220-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Regression analysis and categorical agreement of fluconazole disk zone diameters and minimum inhibitory concentration by broth microdilution of clinical isolates of Candida"],"prefix":"10.1016","volume":"27","author":[{"given":"P.","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2017.02.004_bib0130","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc6212","article-title":"Bench-to-bedside review: Candida infections in the intensive care unit","volume":"12","author":"M\u00e9an","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0135","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0140","doi-asserted-by":"crossref","first-page":"e1003550","DOI":"10.1371\/journal.ppat.1003550","article-title":"Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm","volume":"9","author":"Papon","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0145","first-page":"270","article-title":"A review of Candida species causing blood stream infection","volume":"30","author":"Giri","year":"2012","journal-title":"Int J Med Microbiol"},{"year":"2012","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement. CLSI Document M27-S4","author":"Clinical Laboratory Standards Institute (CLSI)","key":"10.1016\/j.mycmed.2017.02.004_bib0150"},{"year":"2004","series-title":"Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts; Approved Guideline. NCCLS document M44-A","author":"National Committee for Clinical Laboratory Standards (NCCLS)","key":"10.1016\/j.mycmed.2017.02.004_bib0155"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0160","series-title":"CLSI Document M44-S3","article-title":"Zone diameter interpretative standards, corresponding minimal inhibitory concentration (MIC) interpretative breakpoints, and quality control limits for antifungal disk diffusion susceptibility testing of yeasts: Informational supplement","author":"Clinical Laboratory Standards Institute (CLSI)","year":"2009"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0165","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1128\/JCM.00952-10","article-title":"Comparative evaluation of the Vitek\u00a02 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 Study","volume":"48","author":"Borghi","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1099\/jmm.0.023739-0","article-title":"Epidemiology of candidaemia in critically ill trauma patients: experiences of a level I trauma centre in North India","volume":"60","author":"Singh","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0175","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3855\/jidc.2623","article-title":"Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India","volume":"7","author":"Chander","year":"2013","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0180","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/JCM.02432-15","article-title":"Agreement of direct antifungal susceptibility testing from positive blood culture bottles with the conventional method for Candida species","volume":"54","author":"Jabeen","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0185","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4103\/0255-0857.167331","article-title":"Ocular infections caused by Candida species: type of species, in vitro susceptibility and treatment outcome","volume":"33","author":"Motukupally","year":"2015","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0190","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1590\/S0036-46652014000600004","article-title":"Susceptibility of Candida spp. isolated from blood cultures as evaluated using the M27-A3 and new M27-S4 approved breakpoints","volume":"56","author":"Santos","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0195","first-page":"122","article-title":"Susceptibility of Candida species to antifungal drugs in Western India","volume":"5","author":"Vaghela","year":"2015","journal-title":"Nat J Med Res"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0200","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7883\/yoken.JJID.2005.344","article-title":"Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital","volume":"58","author":"Capoor","year":"2005","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0205","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00134-014-3603-2","article-title":"Incidence, characteristics and outcome of ICU-acquired candidemia in India","volume":"41","author":"Chakrabarti","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0210","first-page":"DC01","article-title":"Comparative analysis of disc diffusion and e-test with broth micro-dilution for susceptibility testing of clinical Candida isolates against amphotericin\u00a0b, fluconazole, voriconazole and caspofungin","volume":"9","author":"Kumar","year":"2015","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0215","doi-asserted-by":"crossref","first-page":"e28057","DOI":"10.5812\/jjm.28057","article-title":"In vitro susceptibilities of Candida albicans isolates to antifungal agents in Tokat, Turkey","volume":"8","author":"Yenisehirli","year":"2015","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0220","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1128\/AAC.01035-13","article-title":"Antifungal susceptibilities of Candida isolates causing bloodstream infections at a medical center in Taiwan, 2009\u20132010","volume":"58","author":"Huang","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0225","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1590\/S1517-83822012000100031","article-title":"Susceptibility tests of oropharyngeal Candida albicans from Egyptian patients to fluconazole determined by three methods","volume":"43","author":"El-Mashad","year":"2012","journal-title":"Braz J Microbiol"},{"year":"2008","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard. CLSI document M27-A3","author":"Clinical Laboratory Standards Institute (CLSI)","key":"10.1016\/j.mycmed.2017.02.004_bib0230"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0235","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/CMR.19.2.435-447.2006","article-title":"Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing","volume":"19","author":"Pfaller","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0240","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1128\/JCM.36.11.3429-3432.1998","article-title":"Fluconazole disk diffusion susceptibility testing of Candida species","volume":"36","author":"Kirkpatrick","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0245","first-page":"176","article-title":"Species distribution and susceptibility profile of yeasts isolated from blood cultures: results of a multicenter active laboratory-based surveillance study in Argentina","volume":"43","author":"C\u00f3rdoba","year":"2011","journal-title":"Rev Argent Microbiol"},{"key":"10.1016\/j.mycmed.2017.02.004_bib0250","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/JCM.01900-06","volume":"45","author":"Espinel-Ingroff","year":"2007","journal-title":"J Clin Microbiol"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523316301731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523316301731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:18:03Z","timestamp":1761110283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523316301731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1156523316301731"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.02.004","relation":{},"ISSN":["1156-5233"],"issn-type":[{"type":"print","value":"1156-5233"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regression analysis and categorical agreement of fluconazole disk zone diameters and minimum inhibitory concentration by broth microdilution of clinical isolates of Candida","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2017.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}